Colgate-Palmolive (India) Ltd Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Colgate-Palmolive (India) Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Colgate-Palmolive (India) Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Colgate-Palmolive (India) Ltd — get its next earnings analysis in your feed
How does Colgate-Palmolive (India) Ltd rank vs peers in Personal Products?
Pro featureHow does Colgate-Palmolive (India) Ltd rank in Personal Products?
Compare Colgate-Palmolive (India) Ltd against every Personal Products company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Colgate-Palmolive (India) Ltd's management said in earlier quarters
Others in Personal Products this season
- Anondita Medicare Ltd (Q3 FY26)
Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from
- Bajaj Consumer (Q2 FY27)
Q2 FY27 Net Sales Value: INR 332.7 Cr., up 27.3% YoY (Page 23) . Key investor presentation takeaways from Bajaj Consumer Care Ltd's Q2 FY27 investor presentatio
- Anondita Medicare Ltd (Q4 FY26)
Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…
- Cupid Ltd (Q4 FY24)
6,289 Lakhs, up 57.04% QoQ and 51.59% YoY from Rs. Key concall takeaways from Cupid Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.